COMPANY ›› About
 

Chairman                
  Ha, Chang-Wha    





¡® Service to all people through disease prevention ¡¯
This is the mission of KOREA VACCINE for the past 50 years.

  Specializing in production of preventive medicine and medical devices, KOREA VACCINE has contributed to people's health since it was established in Jan. 1956. After a chairman Ha, Chang-Wha was inaugurated in January,1976, KOREA VACCINE has strived to research, develop, produce, and supply high quality human vaccines and medical devices (including syringes, catheters, intravenous infusion sets, etc.).
   The Medical device division has completed suitable system for KGMP in the end of Aug. 2001. Our division devotes it to manufacturing the highest quality and safest products by using carefully selected materials that are nontoxic and harmless to the human body. We pride ourselves on manufacturing products with cutting edge automated production systems while rigorously inspecting product quality throughout the production process. To this end we conduct rigid quality control through perfect sterility tests, animal experiments, physical tests, and chemical tests, among many other techniques. Also, the Unit exports high quality syringes to the many overseas markets including the US, India, Taiwan, Pakistan, the Republic of South Africa, and Russia. In 2002, the Unit obtained the CE Mark, which signifies a European standard of quality in roads into the European market in 2002.
   Since 1991 the Pharmaceutical division has been capable of manufacturing 10 million doses per year due to its enlarged factory which was relocated into the Banwol Industrial Complex in Ansan. Also, the GMP factory at the global level was completed in April 2006. This required that all facilities, structures, and instruments get through IQ, OQ, PQ, and validation to secure the global quality competitiveness. In 2007 a pre-filled syringe line with the world¡¯s larges productivity (30,000 doses per unit hour) and the automated production system completed as well. Currently, the division is increase in the development and supplying the new products of preventive vaccines in cooperation with leading pharmaceutical companies like BCG Laboratory in Japan, Research Institute for Microbial Diseases of Osaka University (BIKEN), Sanofi-Pasteur, CSL, MSD, Wyeth, and Baxter etc. Finally, the department is making every effort to increase customer satisfaction by daily & direct delivery system to clinics and hospitals through 7 warehouses national-wide located in Seoul, Kyungin, Gwangju, Masan, Busan, Daegu, and Daejeon. Actually the department has the most leading logistics system for delivery of biologics products in Korea. The system has been affirming designated temperature conditions during the cold-chain delivery through overall validating 3 main units (warehouse, vehicle, carrying box).
   With the mission ¡®Service to all people through disease prevention¡¯, we all will do our best to contribute to human health through research and development of high quality drugs and the manufacturing of superior quality products through a ceaseless effort and commitment to safety and quality control, It is our goal to enable a healthy society of all mankind in the 21st century.

Sincerely,

Koreavaccine Co.,Ltd.
Chairman  Ha, Chang-Wha

KOREA VACCINE CO., LTD.